Post Transplant Donor Lymphocyte Infusion
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)
- Status
- UNKNOWN
- Phase
- PHASE2
Stem Cell Transplantation for Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE3
Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure
- Status
- TERMINATED
- Phase
- PHASE2
Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
- Status
- COMPLETED
- Phase
- PHASE2
MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).
- Status
- COMPLETED
- Phase
- PHASE2
Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers
- Status
- TERMINATED
- Phase
- PHASE2
AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1
Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS)
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2